The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
Open Access
- 23 June 2015
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 37 (5) , 709-716
Abstract
Background Heartburn and other symptoms of gastro-oesophageal reflux occur in ~30 % of survey respondents in multiple countries worldwide. Heartburn and acid regurgitation are common complaints in the pharmacy, where patients frequently seek relief through medication and advice. The growing number of proton-pump inhibitors available in the over-the-counter setting provides an efficacious choice to patients experiencing frequent heartburn. Pharmacists can assist patients in their treatment decisions whilst inquiring about alarm symptoms that should prompt a physician referral. Aim of the review Provide pharmacists with a review of current clinical research and expert guidelines on use of over-the-counter proton-pump inhibitors. Methods This narrative review was conducted to identify publications relevant to the following themes: overview of available treatments for frequent episodes of heartburn/acid regurgitation; treatment algorithms providing guidance on when to use over-the-counter proton-pump inhibitors; and the role of the pharmacist in the use of over-the-counter proton-pump inhibitors. Results Frequent symptoms of acid reflux, such as heartburn and acid regurgitation, can interfere substantially with daily life activities. Proton-pump inhibitors are the most efficacious treatment for frequent reflux symptoms and are recommended as an appropriate initial treatment in uncomplicated cases. Proton-pump inhibitors have varying pharmacokinetics and pharmacodynamics across the class; 20 mg esomeprazole has higher bioavailability and exposure than over-the-counter omeprazole, for example. However, differences in clinical efficacy for symptom relief have not been demonstrated. The safety and tolerability of proton-pump inhibitors have been well established in clinical trial and post-marketing settings, and use of a short regimen is associated with a very low likelihood of missing a more serious condition. Pharmacists can assist patients with accurate self-diagnosis by asking short, simple questions to characterize the nature, severity, and frequency of symptoms. Additionally, pharmacists can inquire about alarm symptoms that should prompt referral to a physician. Pharmacists should inform those patients for whom over-the-counter proton-pump inhibitors are appropriate on their proper use. Conclusion Over-the-counter proton-pump inhibitors have a valuable role in the treatment of frequent heartburn. Pharmacists have the opportunity to guide patients through selection of the best treatment option for their symptoms.Keywords
This publication has 55 references indexed in Scilit:
- Population-based assessment of heartburn in urban Black AmericansDiseases of the Esophagus, 2012
- Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trialBMC Gastroenterology, 2012
- Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational StudiesKorean Journal of Family Medicine, 2012
- Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed GuidelinesDigestion, 2009
- Lansoprazole 15 mg Once Daily for 14 Days Is Effective for Treatment of Frequent Heartburn: Results of 2 Randomized, Placebo-Controlled, Double-Blind StudiesPostgraduate Medicine, 2009
- Do calcium antagonists contribute to gastro‐oesophageal reflux disease and concomitant noncardiac chest pain?British Journal of Clinical Pharmacology, 2007
- Acid control with esomeprazole and lansoprazole: A comparative dose–response studyScandinavian Journal of Gastroenterology, 2007
- Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatmentAlimentary Pharmacology & Therapeutics, 2006
- Comparison of Prilosec OTCTM (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburnJournal of Clinical Pharmacy and Therapeutics, 2005
- The Risks and Benefits of an Rx-to-OTC SwitchMedical Care, 1990